Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
IMDXInsight Molecular Diagnostics Inc.
| Figure | IMDXInsight Molecular Diagnostics Inc.FY2025 · Dec |
|---|---|
| Revenue | $4.06M |
| Revenue, yoy | +115.6% |
| Net income | $50.22M |
| Net income, yoy | +17.2% |
| Net margin | -1,238.5% |
| Free cash flow | $25.37M |
| FCF margin | -625.6% |
| EPS, diluted | $1.65 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed